ProjectSENSITIZE (Studie)
Basic data
Title:
SENSITIZE (Studie)
Duration:
14/11/2017 to 31/12/2020
Abstract / short description:
Unverblindete, multizentrische Studie der Phase Ib/II zu 4SC-202 in Kombination mit Pembrolizumab bei Patienten mit nicht resezierbarem kutanem Melanom im Stadium III / metastasiertem kutanem Melanom im Stadium IV mit primärer Refraktärität gegen / Nichtansprechen auf eine frühere Anti-PD-1-Therapie
Keywords:
melanoma
Melanom
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Planegg, Bayern, Germany